Drugs / G-CSF
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT00906945 | Feb 2011 → Nov 2012 | acute myeloid leukemia | Washington University School of Medicine | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | G-CSF | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00906945 ↗ |
| Action | Inhibit | “G-CSF, which down regulates SDF-1 expression” NCT00906945 ↗ |
| Route | Subcutaneous | “G-CSF 10 mcg/kg SQ on Days 1-8” NCT00906945 ↗ |